Written Question·Department of Health and Social Care·UIN 15739
Medicines and Healthcare products Regulatory Agency: Fees and Charges
Tabled: 25 November 2024
Answered: 2 December 2024
Question
Jim Shannon
Democratic Unionist Party — Strangford
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the proposed reform of Medicines and Healthcare products Regulatory Agency statutory fees on investment in the UK market by medical technolo
Answer
Karin SmythThe Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices, and blood components for transfusion in the United Kingdom.Most of the MHRA’s income comes from charging fees for its services. Its fees are set to recove...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 15739) →